EDGEWELL PERSONAL CARE Co (EPC) Form 8-K — Aug 5, 2026
Edgewell Personal Care reported third quarter fiscal 2026 net sales of $570.1 million, up 1.7% year over year, with organic net sales up 1.1% as the business returned to growth, led by a 3.0% organic increase in North America across Sun, Skin Care and Grooming. Adjusted EPS held flat at $0.72, which the company said exceeded expectations, while GAAP diluted EPS fell to $0.26 from $0.46 a year ago on $24.5 million of restructuring costs; adjusted EBITDA came in at $78.9 million versus $81.2 million in the prior year quarter.
Key figures
- Eps
- $0.26 GAAP diluted (vs. $0.46 prior year); $0.72 adjusted (flat YoY)
- Revenue
- $570.1 million (Q3 FY2026); $1,512.4 million nine months
- Guidance
- FY2026: reported net sales +1.3% to +1.8% (previously +0.8% to +3.8%); organic flat to +0.5%; adjusted EPS $1.80-$2.00 (previously $1.70-$2.10); adjusted EBITDA $250-260 million; adjusted free cash flow $80-110 million; ~$92 million restructuring charges
- Net Income
- $12.3 million from continuing operations in Q3 ($13.7 million total incl. discontinued ops); nine-month net loss of $62.6 million
- Total Debt
- $1,279.2 million gross debt
- Revenue Yoy
- +1.7% (Q3); organic +1.1%
- Total Assets
- $3,535.4 million
- Cash Position
- $397.1 million
- Gross Margin
- 42.5% GAAP, down 210 bps; adjusted 44.5%, down 30 bps
- Dividend Per Share
- $0.15 quarterly, payable October 8, 2026
- Adjusted EBITDA Q3
- $78.9 million (vs. $81.2 million prior year)
- Buyback Availability
- ~$85 million under 2025 authorization
- Revolver Availability
- $418.8 million
- Adjusted Net Debt Leverage
- 3.7x
- Restructuring Charges Q3
- $24.5 million pre-tax
- Feminine Care Sale Proceeds
- $338.9 million (nine months)
- North America Organic Growth
- +3.0%
- International Organic Growth
- -1.4%
- Wet Shave Segment Profit Change
- -20.9%
- Impairment Charges nine Months
- $37.4 million
- Sun And Skin Care Net Sales Change
- +5.7%
Price after filing
Close on the filing date to close N calendar days later (from $27.59). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.